Search Results - "Tajiri, Hirotaka"

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease by Higuchi, Nobito, Kato, Masaki, Shundo, Yuki, Tajiri, Hirotaka, Tanaka, Masatake, Yamashita, Naoki, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakamuta, Makoto, Takayanagi, Ryoichi, Enjoji, Munechika

“…Aim:  Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of liver dysfunction and its incidence has increased markedly. However, the…”
Get full text

Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma by Yada, Masayoshi, Masumoto, Akihide, Motomura, Kenta, Tajiri, Hirotaka, Morita, Yusuke, Suzuki, Hideo, Senju, Takeshi, Koyanagi, Toshimasa

“…AIM:To determine significant indicators for the efficacy of sorafenib in patients with advanced hepatocellular carcinoma(HCC).METHODS:A total of 46 patients…”
Get full text

Frequency of gastroesophageal reflux disease (GERD) as a complication in patients with chronic liver diseases: estimation of frequency scale for the system of GERD by Ueda, Akihiro, Enjoji, Munechika, Kato, Masaki, Yamashita, Naoki, Horikawa, Yuki, Tajiri, Hirotaka, Kotoh, Kazuhiro, Nakamuta, Makoto, Takayanagi, Ryoichi

“…Recently, a questionnaire, Frequency Scale for the System of GERD (FSSG), has been estimated to be clinically useful for the initial diagnosis of…”
Get more information

Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C by YAMASHITA, Naoki, ENJOJI, Munechika, KOTOH, Kazuhiro, KATO, Masaki, UEDA, Akihiro, HORIKAWA, Yuki, TAJIRI, Hirotaka, HIGUCHI, Nobito, KINUKAWA, Naoko, NAKAMUTA, Makoto, TAKAYANAGI, Ryoichi

“…OBJECTIVE:  Hyperuricemia has been reported as being an adverse effect of pegylated‐interferon‐α2b (Peg‐IFNα2b) and ribavirin combination therapy for chronic…”
Get full text

Investigation of hyperuricemia during pegylated-interferon-alpha2b plus ribavirin combination therapy in patients with chronic hepatitis C by Yamashita, Naoki, Enjoji, Munechika, Kotoh, Kazuhiro, Kato, Masaki, Ueda, Akihiro, Horikawa, Yuki, Tajiri, Hirotaka, Higuchi, Nobito, Kinukawa, Naoko, Nakamuta, Makoto, Takayanagi, Ryoichi

“…Hyperuricemia has been reported as being an adverse effect of pegylated-interferon-alpha2b (Peg-IFNalpha2b) and ribavirin combination therapy for chronic…”
Get full text